Table 1.

Gene expression in adipose-depleted MECs following 8 h of BrCr treatment

	Adipose-Depleted MECs
Functional Category	Control	BrCr	Fold change
Milk protein genes
Csn2	1.43	0.86	−1.65c
Lalba	1.36	0.67	−2.01b
Wap	1.10	0.88	N/C
Glycolysis and pentose shunt
Glut1	1.95	0.54	−3.59c
G6pd2	0.91	0.38	−2.43b
AldoC	1.69	0.37	−2.93b
Gapdh	1.24	0.55	−2.25c
Me1	1.09	0.50	−2.16b
De novo fatty acid synthesis
Slc25a1	1.69	0.37	−4.59a
Acly	1.65	0.30	−5.45d
Acc1α	1.44	0.22	−6.43d
Fasn	1.08	0.34	−3.13b
Thrsp	0.77	0.69	N/C
TAG synthesis and β-oxidation
Dgat1	1.08	0.48	−2.24b
Scd2	2.03	0.10	−19.46c
Fads1	1.44	0.40	−3.62c
Acaa2	0.50	0.52	N/C
Acadl	0.46	0.63	N/C
Regulatory factors
Akt1	2.55	0.92	−2.77c
Prlr-Long	0.96	0.37	−2.60d
Srebp1a	0.77	0.38	−2.05b
Srebp1c	0.74	0.22	−3.34b

Gene expression in adipose-depleted mammary epithelial cells (MECs) following 8-h bromocriptine (BrCr) treatment. Genes are grouped into functional categories. Values are mean normalized transcript copy numbers for that gene using standard curve-based qRT-PCR; n = 5 mice per condition. Fold change is calculated as −1/(BrCr/Control). Statistical significance: ^aP ≤ 0.05, ^bP ≤ 0.01, ^cP ≤ 0.001, ^dP ≤ 0.0001. N/C, no statistical change, using Excel's t-test function.